✦ LIBER ✦

1099 Progression to muscle invasive disease of G1-2/low grade non-muscle invasive bladder cancer: Never at the first recurrence

✍ Scribed by Palou, J.; Rodríguez Faba, O.; Gaya, J.M.; Skrobot, S.; Algaba, F.; Novoa, R.; Esquena, S.; Villavicencio, H.

Book ID: 122202134
Publisher: Elsevier Science
Year: 2014
Tongue: English
Weight: 108 KB
Volume: 13
Category: Article
ISSN: 1569-9056
DOI: 10.1016/S1569-9056(14)61079-4

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

MP65-18 PROGRESSION TO MUSCLE INVASIVE D

MP65-18 PROGRESSION TO MUSCLE INVASIVE DISEASE OF G1-2/LOW GRADE NON-MUSCLE INVASIVE BLADDER CANCER: NEVER AT THE FIRST RECURRENCE

✍ Palou, Juan; Rodríguez Faba, Oscar; Gaya, Josep Maria; Skrobot, Sergio; Algaba, 📂 Article 📅 2014 🏛 Lippincott Williams and Wilkins 🌐 English ⚖ 139 KB

Recurrence and Progression of Disease in

Recurrence and Progression of Disease in Non–Muscle-Invasive Bladder Cancer: From Epidemiology to Treatment Strategy

✍ Bas W.G. van Rhijn; Maximilian Burger; Yair Lotan; Eduardo Solsona; Christian G. 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 345 KB

396 TUMORIGENIC AND PROGNOSTIC SIGNIFICA

396 TUMORIGENIC AND PROGNOSTIC SIGNIFICANCE OF RASSF1A EXPRESSION IN NON-MUSCLE-INVASIVE LOW-GRADE (WHO G1 AND G2) BLADDER CANCER

✍ HA, Yun-Sok; KIM, Yong-June; KIM, Jeong Hyun; Lee, Sang-Cheol; KIM, Isaac Y.I.; 📂 Article 📅 2012 🏛 Lippincott Williams and Wilkins 🌐 English ⚖ 141 KB

756 Prediction of progression in patient

756 Prediction of progression in patients with non-muscle invasive bladder cancer based on histologic grade, T stage, recurrence rate and bladder neck involvement: The BN-GTR model

✍ Fujii, Y.; Kobayashi, S.; Koga, F.; Yokoyama, M.; Yoshida, S.; Ishioka, J.; Mats 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 107 KB

177 THE PROGNOSTIC VALUE OF FGFR3 MUTATI

177 THE PROGNOSTIC VALUE OF FGFR3 MUTATIONAL STATUS FOR DISEASE RECURRENCE AND PROGRESSION DEPENDS ON ALLELIC LOSSES AT 9P22: A PROSPECTIVE AND PRELIMINARY STUDY IN 58 NON-MUSCLE INVASIVE BLADDER CANCER PATIENTS

✍ G. Ploussard; H. Soliman; F. Dubosq; J. Vérine; F. Desgrandchamps; Thé H. De; P. 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 176 KB

433 EFFICACY AND SAFETY OF MYCOBACTERIAL

433 EFFICACY AND SAFETY OF MYCOBACTERIAL CELL WALL DNA COMPLEX IN THE TREATMENT OF PATIENTS WITH NON-MUSCLE INVASIVE BLADDER CANCER AT HIGH RISK OF PROGRESSION AND WHO ARE REFRACTORY TO BCG

✍ A. Morales; H.W. Herr; G.D. Steinberg; A.M. Kamat; R. Given; C. Lihou; Z. Cohen 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 176 KB